Clinical Trials Logo

Clinical Trial Summary

Tonsillectomy and adenoidectomy is one of the most common pediatric surgeries, and agitation and severe postoperative pain have been considered a very common complications. Dexmedetomidine mainly inhibits the release of norepinephrine by acting on the α-adrenergic receptor of the brainstem nucleus, which can produce good sedative effects. Hydromorphone has a longer duration of action than fentanyl, and it also has a certain sedative effect. The combination of the two is more conducive to the management of postanesthetic agitation and pain. This study was to compare the effect of different doses of dexmedetomidine combined with hydromorphone in the sedation and analgesia after pediatric tonsillectomy and adenoidectomy.


Clinical Trial Description

The computer generates random numbers to allocate patients into different group. Trained research staff who are not involved in the study collect the data. The observer who only stayed in PACU was blinded to the allocation and responsible to record the data. The primary measurement are pain scores, PAED scores, coughing was evaluated on a 9-point scale (1= no coughing, 2= minimal coughing, one or two times, 3-4= moderate coughing, 3-4 times, 5-6= moderate coughing, more than 5 times, 7-8= severe coughing, more than 10 times, 9= laryngospasm), and extubation time. The secondary measurements are the time to discharge from the post-anaesthesia care unit, and the number of postoperative desaturation. A sample size of 57 was determined by analysis based on the assumption of the decline of extubation time from other similar study and α=0.05,β=0.2. The continuous variables were presented as means ± SD and the categorical variables were expressed as frequency. The outcome of interest is extubation time decline. ;


Study Design


Related Conditions & MeSH terms

  • Agitated; State, Acute Reaction to Stress
  • Stress Disorders, Traumatic, Acute

NCT number NCT03760809
Study type Interventional
Source Eye & ENT Hospital of Fudan University
Contact
Status Completed
Phase Phase 4
Start date January 4, 2019
Completion date April 1, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05543681 - IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's Phase 2
Completed NCT03862391 - Does Low Flow Anesthesia Reduce Postanaesthetic Emergence Agitation? Phase 4
Completed NCT04293081 - Preemptive Chlorepheniramine Maleate Reducing Postoperative Agitation N/A
Completed NCT04514432 - Mindful Melody: Feasibility of Implementing Music Listening on an Inpatient Psychiatric Unit and Its Relation to the Use of As Needed Medications for Acute Agitation
Completed NCT03213782 - Effect of Nature Based Sounds' Intervention on Agitation and Anxiety of Patients Admitted in Intensive Care Units. N/A